Ying Wu

Director & Head of Human Genetics Eisai Co., Ltd.

Thursday 25th September 2025

The Integration of Human Genomics & Proteomics to Advance Biomarker Discovery & Patient Stratification

12:20 pm

Proteogenomics has become a powerful tool to improve thebunderstanding of disease mechanisms, identify new drug targetsband biomarkers, and facilitate the patient subgrouping
The emerging proteome resources and cutting-edge analytic approaches provide novel opportunities for proteogenomic studies
The utilization of AI/ML in building polygenic risk scores and protein risk scores will open a new avenue for disease mechanistic and clinical translation